Patents by Inventor Kshitij Chhabilbhai Thakkar

Kshitij Chhabilbhai Thakkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
    Patent number: 7262297
    Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: August 28, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Steven Joseph Berthel, Adrian Wai-Hing Cheung, Kyungjin Kim, Kshitij Chhabilbhai Thakkar, Weiya Yun
  • Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
    Patent number: 7226915
    Abstract: This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: June 5, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Steven Joseph Berthel, Kshitij Chhabilbhai Thakkar
  • 5-substituted-six-membered heteroaromatic glucokinase activators
    Patent number: 7132425
    Abstract: The present invention provides a compound according to formula I where the substituent designations are provided in the specification. Pharmaceutical compositions comprising a compound according to formula I are also provided.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: November 7, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Shaoqing Chen, Wendy Lea Corbett, Kevin Richard Guertin, Nancy-Ellen Haynes, Robert Francis Kester, Francis A. Mennona, Steven Gregory Mischke, Yimin Qian, Ramakanth Sarabu, Nathan Robert Scott, Kshitij Chhabilbhai Thakkar
  • Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
    Publication number: 20040235872
    Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
    Type: Application
    Filed: April 30, 2004
    Publication date: November 25, 2004
    Inventors: Steven Joseph Berthel, Adrian Wai-Hing Cheung, Kyungjin Kim, Kshitij Chhabilbhai Thakkar, Weiya Yun
  • Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
    Publication number: 20040229890
    Abstract: This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
    Type: Application
    Filed: April 30, 2004
    Publication date: November 18, 2004
    Inventors: Steven Joseph Berthel, Kshitij Chhabilbhai Thakkar
  • 5-Substituted-six-membered heteroaromatic glucokinase activators
    Publication number: 20040147748
    Abstract: The present invention provides a compound according to formula I 1
    Type: Application
    Filed: December 10, 2003
    Publication date: July 29, 2004
    Inventors: Shaoqing Chen, Wendy Lea Corbett, Kevin Richard Guertin, Nancy-Ellen Haynes, Robert Francis Kester, Francis A. Mennona, Steven Gregory Mischke, Yimin Qian, Ramakanth Sarabu, Nathan Robert Scott, Kshitij Chhabilbhai Thakkar